<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132794">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01864278</url>
  </required_header>
  <id_info>
    <org_study_id>CL0004-01</org_study_id>
    <nct_id>NCT01864278</nct_id>
  </id_info>
  <brief_title>Lutonix Global SFA Registry</brief_title>
  <official_title>A Prospective, Global Multicenter, Single Arm Real-World Registry Investigating the Clinical Use and Safety of the LUTONIX Drug Coated PTA Dilatation Catheter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>C. R. Bard</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bard Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>C. R. Bard</source>
  <oversight_info>
    <authority>Germany: regional Ethics Committees and Freiburger Ethikkommission International</authority>
    <authority>Poland: Ethics Committee at Klinika Chirurgii Naczyniowej, Lublin, PL</authority>
    <authority>Austria: regional Ethics Committees</authority>
    <authority>Switzerland: Ethics Committee at the Kantonsspital Aarau, CH</authority>
    <authority>France: &quot;Commission nationale de l'informatique et des libertés&quot; and local Ethics Committee</authority>
    <authority>Italy: local Ethics Committees</authority>
    <authority>Greece: local Ethics Committees</authority>
    <authority>The Netherlands: Ethics Committee of the TweeSteden Ziekenhuis, Tilburg, NL</authority>
    <authority>Belgium: Ethics Committee of the ZNA-Campus Middelheim, Antwerp, B</authority>
    <authority>Spain: local Ethics Committees</authority>
    <authority>UK: central Ethics Committee, to be determined after IRAS approval</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The registry will enroll patients with claudication or ischemic rest pain and an
      angiographically significant lesion in the superficial femoral or popliteal artery.
      Subjects will be treated with the LUTONIX  Drug Coated PTA Dilatation Catheter carrying the
      CE Mark per current Instructions for Use(IFU) and followed clinically for a minimum of 2
      years.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Freedom from Target Lesion Revascularization (TLR)</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Efficacy: Freedom from TLR at 12 months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedom from Target Vessel Revascularization(TVR), major index limb amputation, and device- and procedure-related death</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Safety:  Freedom at 30 days from TVR, major index limb amputation, and device- and procedure-related death</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Peripheral Artery Disease</condition>
  <arm_group>
    <arm_group_label>Lutonix Drug Coated Balloon</arm_group_label>
    <description>Paclitaxel coated ballooncatheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lutonix Drug Coated Balloon</intervention_name>
    <description>Subject will receive treatment with the Lutonix Drug Coated Balloon</description>
    <arm_group_label>Lutonix Drug Coated Balloon</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hospital patients (global registry)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or non-pregnant female ≥18 years of age;

          -  Rutherford Clinical Category ≤ 4;

          -  Patient is willing to provide 5-year informed consent and comply with the required
             follow up;

          -  Stenotic or obstructive vascular lesions of the femoropopliteal artery;

          -  Lesion(s) can be treated with available LUTONIX Drug Coated PTA Dilatation Catheter
             device size matrix per current IFU;

          -  At least one patent native outflow artery to the ankle free from significant lesion
             (≥50% stenosis) as confirmed by angiography (treatment of outflow disease is NOT
             permitted; treatment of in-flow disease is permitted prior to treatment with the
             LUTONIX Drug Coated PTA Dilatation Catheter).

        Exclusion Criteria:

          -  Patient is currently participating in an investigational drug or device study;

          -  Inability to take recommended medications as stated in the IFU or non-controllable
             allergy to contrast;

          -  Pregnant or planning on becoming pregnant or men intending to father a child;

          -  Rutherford Class  &gt; 4

          -  Known inadequate distal outflow or planned future treatment of vascular disease
             distal to the target lesion
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ruth Proebe</last_name>
    <email>ruth.proebe@crbard.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Wien</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Renate Koppensteiner, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ZNA Campus Middelheim</name>
      <address>
        <city>Antwerp</city>
        <zip>2020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Sven Vercauteren, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Le Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Eric Steinmetz, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinen Hospital Huesten</name>
      <address>
        <city>Arnsberg</city>
        <zip>59759</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Michael Lichtenberg, Dr.med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Bielefeld</name>
      <address>
        <city>Bielefeld</city>
        <zip>33617</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Guenther Wittenberg, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Diakoniewerk Muenchen</name>
      <address>
        <city>Muenchen</city>
        <zip>80331</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Peter von Bilderling, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Barmherzigen Brueder</name>
      <address>
        <city>Regensburg</city>
        <zip>93049</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Niels Zorger, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medinos Kliniken Sonneberg</name>
      <address>
        <city>Sonneberg</city>
        <zip>96515</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Marcus Thieme, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kreiskrankenhaus Viechtach</name>
      <address>
        <city>Viechtach</city>
        <zip>94234</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Delgado Perez, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Weiden</name>
      <address>
        <city>Weiden</city>
        <zip>92637</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Christian Paetzel, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University General Hospital of Patras</name>
      <address>
        <city>Patras</city>
        <zip>26504</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Dimitrios Siablis, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AO Cardinal Massaia</name>
      <address>
        <city>Asti</city>
        <zip>14100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Dr. Gaggiano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Crema</name>
      <address>
        <city>Crema</city>
        <zip>26013</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Dr. Spinazzola</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Umberto I</name>
      <address>
        <city>Roma</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Prof. Luciano Bresadola</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Policlinico San Donato</name>
      <address>
        <city>San Donato Milanese</city>
        <zip>20097</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Dr. Giovanni Nano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera della Valtellina e dalla Valchiavenna</name>
      <address>
        <city>Sondalo</city>
        <zip>23035</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Dr. Marco Udini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AO Ordine Mauriziano</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Dr. Franco Nessi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>TweeSteden Zuikenhuis</name>
      <address>
        <city>Tilburg</city>
        <zip>5042</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Jan Seelen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersytecki nr 2 im. Biziel</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-168</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Karol Suppan, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinika Chirurgii Naczyniowej</name>
      <address>
        <city>Lublin</city>
        <zip>20-081</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Pietura Radoslaw, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Szpital Kliniczny Przemienienia Panskiego</name>
      <address>
        <city>Poznan</city>
        <zip>61-848</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Grzegorz Oszkinis, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Voivodship Specialist Hospital</name>
      <address>
        <city>Torun</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Pawel Drojecki, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Vincent Riambau, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Aarau</name>
      <address>
        <city>Aarau</city>
        <zip>5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Ernst Groechenig, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Liverpool</name>
      <address>
        <city>Liverpool</city>
        <zip>L7 8XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Richard McWilliams, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Narayan Karunanithy, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wythenshawe Hospital</name>
      <address>
        <city>Manchester</city>
        <zip>M23 9LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Stephen Butterfield, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Manchester Royal Infirmary</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Finn Farquharson, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <zip>WE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Proebe</last_name>
      <email>ruth.proebe@crbard.com</email>
    </contact>
    <investigator>
      <last_name>Sumaira MacDonald, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 3, 2014</lastchanged_date>
  <firstreceived_date>May 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
